Erysipelas of the upper extremity following locoregional therapy for breast cancer.
Identifieur interne : 003894 ( PubMed/Checkpoint ); précédent : 003893; suivant : 003895Erysipelas of the upper extremity following locoregional therapy for breast cancer.
Auteurs : Nagi S. El Saghir [Liban] ; Zaher K. Otrock ; Abdul Rahman N. Bizri ; Marwan M. Uwaydah ; Gerard O. OghlakianSource :
- Breast (Edinburgh, Scotland) [ 0960-9776 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Antibactériens (usage thérapeutique), Femelle, Humains, Lymphadénectomie (effets indésirables), Lymphoedème (étiologie), Mastectomie (effets indésirables), Membre supérieur, Pénicillines (usage thérapeutique), Récidive, Sujet âgé, Tumeurs du sein (), Érysipèle (traitement médicamenteux), Érysipèle (étiologie).
- MESH :
- effets indésirables : Lymphadénectomie, Mastectomie.
- traitement médicamenteux : Érysipèle.
- usage thérapeutique : Antibactériens, Pénicillines.
- étiologie : Lymphoedème, Érysipèle.
- Adulte, Adulte d'âge moyen, Aisselle, Femelle, Humains, Membre supérieur, Récidive, Sujet âgé, Tumeurs du sein.
English descriptors
- KwdEn :
- Adult, Aged, Anti-Bacterial Agents (therapeutic use), Axilla, Breast Neoplasms (surgery), Erysipelas (drug therapy), Erysipelas (etiology), Female, Humans, Lymph Node Excision (adverse effects), Lymphedema (etiology), Mastectomy (adverse effects), Middle Aged, Penicillins (therapeutic use), Recurrence, Upper Extremity.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Penicillins.
- adverse effects : Lymph Node Excision, Mastectomy.
- drug therapy : Erysipelas.
- etiology : Erysipelas, Lymphedema.
- surgery : Breast Neoplasms.
- Adult, Aged, Axilla, Female, Humans, Middle Aged, Recurrence, Upper Extremity.
Abstract
Cellulitis is a well-known complication of lymphedema of the lower extremities. Erysipelas of the upper extremity complicating breast cancer therapy has never been reported in the English-language literature. We describe seven breast cancer patients with erysipelas of the upper extremity. Five had a predisposing injury to the extremity. All patients responded very well to intravenous antibiotics without any sequelae. They had rapid resolution with typical desquamation. No long-term sequelae were seen except for mild increase of lymphedema. Erysipelas should be listed as a rare complication after locoregional therapy for breast cancer. Intravenous penicillin should be used as the initial therapy. Prevention of arm lymphedema and avoidance of any trauma to the arm are important prophylactic measures. Sentinel lymph node biopsy reduces the rate of axillary lymph node dissection and thus should reduce the incidence of lymphedema and erysipelas.
DOI: 10.1016/j.breast.2005.02.011
PubMed: 15990307
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15990307Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Erysipelas of the upper extremity following locoregional therapy for breast cancer.</title><author><name sortKey="El Saghir, Nagi S" sort="El Saghir, Nagi S" uniqKey="El Saghir N" first="Nagi S" last="El Saghir">Nagi S. El Saghir</name><affiliation wicri:level="1"><nlm:affiliation>Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 113-6044, Beirut, Lebanon. nagi.saghir@aub.edu.lb</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 113-6044, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Otrock, Zaher K" sort="Otrock, Zaher K" uniqKey="Otrock Z" first="Zaher K" last="Otrock">Zaher K. Otrock</name></author><author><name sortKey="Bizri, Abdul Rahman N" sort="Bizri, Abdul Rahman N" uniqKey="Bizri A" first="Abdul Rahman N" last="Bizri">Abdul Rahman N. Bizri</name></author><author><name sortKey="Uwaydah, Marwan M" sort="Uwaydah, Marwan M" uniqKey="Uwaydah M" first="Marwan M" last="Uwaydah">Marwan M. Uwaydah</name></author><author><name sortKey="Oghlakian, Gerard O" sort="Oghlakian, Gerard O" uniqKey="Oghlakian G" first="Gerard O" last="Oghlakian">Gerard O. Oghlakian</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15990307</idno><idno type="pmid">15990307</idno><idno type="doi">10.1016/j.breast.2005.02.011</idno><idno type="wicri:Area/PubMed/Corpus">003C51</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C51</idno><idno type="wicri:Area/PubMed/Curation">003C51</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C51</idno><idno type="wicri:Area/PubMed/Checkpoint">003C51</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003C51</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Erysipelas of the upper extremity following locoregional therapy for breast cancer.</title><author><name sortKey="El Saghir, Nagi S" sort="El Saghir, Nagi S" uniqKey="El Saghir N" first="Nagi S" last="El Saghir">Nagi S. El Saghir</name><affiliation wicri:level="1"><nlm:affiliation>Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 113-6044, Beirut, Lebanon. nagi.saghir@aub.edu.lb</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 113-6044, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="Otrock, Zaher K" sort="Otrock, Zaher K" uniqKey="Otrock Z" first="Zaher K" last="Otrock">Zaher K. Otrock</name></author><author><name sortKey="Bizri, Abdul Rahman N" sort="Bizri, Abdul Rahman N" uniqKey="Bizri A" first="Abdul Rahman N" last="Bizri">Abdul Rahman N. Bizri</name></author><author><name sortKey="Uwaydah, Marwan M" sort="Uwaydah, Marwan M" uniqKey="Uwaydah M" first="Marwan M" last="Uwaydah">Marwan M. Uwaydah</name></author><author><name sortKey="Oghlakian, Gerard O" sort="Oghlakian, Gerard O" uniqKey="Oghlakian G" first="Gerard O" last="Oghlakian">Gerard O. Oghlakian</name></author></analytic><series><title level="j">Breast (Edinburgh, Scotland)</title><idno type="ISSN">0960-9776</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Axilla</term><term>Breast Neoplasms (surgery)</term><term>Erysipelas (drug therapy)</term><term>Erysipelas (etiology)</term><term>Female</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (etiology)</term><term>Mastectomy (adverse effects)</term><term>Middle Aged</term><term>Penicillins (therapeutic use)</term><term>Recurrence</term><term>Upper Extremity</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Antibactériens (usage thérapeutique)</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (étiologie)</term><term>Mastectomie (effets indésirables)</term><term>Membre supérieur</term><term>Pénicillines (usage thérapeutique)</term><term>Récidive</term><term>Sujet âgé</term><term>Tumeurs du sein ()</term><term>Érysipèle (traitement médicamenteux)</term><term>Érysipèle (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Penicillins</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term><term>Mastectomy</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Erysipelas</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term><term>Mastectomie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erysipelas</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Érysipèle</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Pénicillines</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term><term>Érysipèle</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Recurrence</term><term>Upper Extremity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Femelle</term><term>Humains</term><term>Membre supérieur</term><term>Récidive</term><term>Sujet âgé</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cellulitis is a well-known complication of lymphedema of the lower extremities. Erysipelas of the upper extremity complicating breast cancer therapy has never been reported in the English-language literature. We describe seven breast cancer patients with erysipelas of the upper extremity. Five had a predisposing injury to the extremity. All patients responded very well to intravenous antibiotics without any sequelae. They had rapid resolution with typical desquamation. No long-term sequelae were seen except for mild increase of lymphedema. Erysipelas should be listed as a rare complication after locoregional therapy for breast cancer. Intravenous penicillin should be used as the initial therapy. Prevention of arm lymphedema and avoidance of any trauma to the arm are important prophylactic measures. Sentinel lymph node biopsy reduces the rate of axillary lymph node dissection and thus should reduce the incidence of lymphedema and erysipelas.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15990307</PMID><DateCreated><Year>2005</Year><Month>10</Month><Day>11</Day></DateCreated><DateCompleted><Year>2005</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2005</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0960-9776</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2005</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Breast (Edinburgh, Scotland)</Title><ISOAbbreviation>Breast</ISOAbbreviation></Journal><ArticleTitle>Erysipelas of the upper extremity following locoregional therapy for breast cancer.</ArticleTitle><Pagination><MedlinePgn>347-51</MedlinePgn></Pagination><Abstract><AbstractText>Cellulitis is a well-known complication of lymphedema of the lower extremities. Erysipelas of the upper extremity complicating breast cancer therapy has never been reported in the English-language literature. We describe seven breast cancer patients with erysipelas of the upper extremity. Five had a predisposing injury to the extremity. All patients responded very well to intravenous antibiotics without any sequelae. They had rapid resolution with typical desquamation. No long-term sequelae were seen except for mild increase of lymphedema. Erysipelas should be listed as a rare complication after locoregional therapy for breast cancer. Intravenous penicillin should be used as the initial therapy. Prevention of arm lymphedema and avoidance of any trauma to the arm are important prophylactic measures. Sentinel lymph node biopsy reduces the rate of axillary lymph node dissection and thus should reduce the incidence of lymphedema and erysipelas.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Saghir</LastName><ForeName>Nagi S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 113-6044, Beirut, Lebanon. nagi.saghir@aub.edu.lb</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otrock</LastName><ForeName>Zaher K</ForeName><Initials>ZK</Initials></Author><Author ValidYN="Y"><LastName>Bizri</LastName><ForeName>Abdul Rahman N</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Uwaydah</LastName><ForeName>Marwan M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Oghlakian</LastName><ForeName>Gerard O</ForeName><Initials>GO</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Breast</MedlineTA><NlmUniqueID>9213011</NlmUniqueID><ISSNLinking>0960-9776</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010406">Penicillins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004886" MajorTopicYN="N">Erysipelas</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010406" MajorTopicYN="N">Penicillins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>08</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2004</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>12</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15990307</ArticleId><ArticleId IdType="pii">S0960-9776(05)00059-7</ArticleId><ArticleId IdType="doi">10.1016/j.breast.2005.02.011</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Liban</li></country></list><tree><noCountry><name sortKey="Bizri, Abdul Rahman N" sort="Bizri, Abdul Rahman N" uniqKey="Bizri A" first="Abdul Rahman N" last="Bizri">Abdul Rahman N. Bizri</name><name sortKey="Oghlakian, Gerard O" sort="Oghlakian, Gerard O" uniqKey="Oghlakian G" first="Gerard O" last="Oghlakian">Gerard O. Oghlakian</name><name sortKey="Otrock, Zaher K" sort="Otrock, Zaher K" uniqKey="Otrock Z" first="Zaher K" last="Otrock">Zaher K. Otrock</name><name sortKey="Uwaydah, Marwan M" sort="Uwaydah, Marwan M" uniqKey="Uwaydah M" first="Marwan M" last="Uwaydah">Marwan M. Uwaydah</name></noCountry><country name="Liban"><noRegion><name sortKey="El Saghir, Nagi S" sort="El Saghir, Nagi S" uniqKey="El Saghir N" first="Nagi S" last="El Saghir">Nagi S. El Saghir</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003894 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003894 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15990307
|texte= Erysipelas of the upper extremity following locoregional therapy for breast cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15990307" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |